-
1.
公开(公告)号:WO2004009158A2
公开(公告)日:2004-01-29
申请号:PCT/US0322267
申请日:2003-07-16
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: CHILDERS ROBERT W , BROWN DAVID S , WARIAR RAMESH , KAROOR SUJATHA , DIN SHAHID , MARTIS LEO , BUCHMANN CODY , SOLTYS PAUL
CPC classification number: A61M1/1696 , A61M1/1656 , A61M1/1658 , A61M1/166 , A61M1/28 , A61M1/284 , A61M1/285 , A61M1/287 , A61M1/288 , A61M2202/0413 , A61M2205/12 , A61M2205/3306 , A61M2205/3327
Abstract: In a peritoneal dialysis embodiment of the present invention, spent dialysate from the patient's peritoneal cavity passes, along a patient loop, through a dialyzer having a membrane that separates waste components from the spent dialysate, wherein the patient loop returns fresh dialysate to the patient's peritoneal cavity. The waste components are carried away in a second regeneration loop to a regeneration unit or sorbent cartridge, which absorbs the waste components. The regeneration unit removes undesirable components in the dialysate that were removed from the patient loop by the dialyzer, for example, excess water (ultrafiltrate or UF), toxins and metabolic wastes. Desirable components can be added to the dialysate by the system, such as glucose and electrolytes. The additives assist in maintaining the proper osmotic gradients in the patient to perform dialysis and provide the necessary compounds to the patient.
Abstract translation: 在本发明的腹膜透析实施方案中,来自患者腹膜腔的用过的透析液沿着患者环路通过具有膜的透析器,该膜将废组分与用过的透析液分开,其中患者环路将新鲜透析液返回至患者的腹膜 腔。 废物组分在第二再生回路中被带走到吸收废物组分的再生单元或吸附剂盒。 再生单元除去透析器中由透析器移除的透析液中不需要的成分,例如过量的水(超滤液或UF),毒素和代谢废物。 理想的组分可以通过该系统添加到透析液中,例如葡萄糖和电解质。 添加剂有助于维持患者适当的渗透梯度以进行透析并向患者提供必需的化合物。
-
">
公开(公告)号:WO03097121A2
公开(公告)日:2003-11-27
申请号:PCT/US0312816
申请日:2003-04-23
Applicant: BAXTER INT
Inventor: PAN LI , WARIAR RAMESH , MARTIS LEO , HOLMES CLIFF , CHILDERS ROBERT , DIN SHAHID
CPC classification number: B01D61/32 , A61M1/1609 , A61M1/28
Abstract: A biosensor capable of monitoring a number of different constituents of a dialysate solution used during dialysis therapy is provided. The biosensor of the present invention includes an integrated array of reactive elements and sensing elements that can be hydraulically coupled to the dialysate solution. In this regard, the biosensor can be utilized to provide on-line monitoring of total solutes removed from a patient during dialysis therapy, infection levels, and/or other desirable parameters such that an overall assessment of dialysis therapy can be readily evaluated.
Abstract translation: 提供能够监测在透析治疗期间使用的透析液的多种不同成分的生物传感器。 本发明的生物传感器包括能够液压耦合到透析液的反应元件和感测元件的集成阵列。 在这方面,生物传感器可用于提供在透析治疗,感染水平和/或其它期望参数期间从患者移除的总溶质的在线监测,使得可以容易地评估透析治疗的总体评估。
-
公开(公告)号:AT520430T
公开(公告)日:2011-09-15
申请号:AT10075249
申请日:2002-10-01
Applicant: BAXTER INT
Inventor: MORTI STAVROULA , KAROOR SUJATHA , DONOVAN BRIAN , HAI TON THAT , KATADA MARI , LU LUIS , MARTIS LEO , MUJAIS SALIM , SANDERS PAUL , SOLTYS PAUL , TANDON RAHUL
IPC: A61M1/16 , A61M1/36 , A61M1/28 , B01D15/00 , B01J20/02 , B01J20/06 , B01J20/20 , B01J20/22 , B01J39/10 , B01J41/10
Abstract: The invention provides a device (32) for removing uremic toxins in a dialysis procedure comprising a body having an inlet (42) and an outlet (44) and defining an interior. The interior includes a layer comprising urease, a layer comprising zirconium oxide, a layer comprising zirconium phosphate, and a layer comprising carbon. The device is constructed and arranged so that a fluid entering the device contacts the zirconium phosphate layer before contacting the urease layer and before contacting the zirconium oxide layer.
-
公开(公告)号:DE60336724D1
公开(公告)日:2011-05-26
申请号:DE60336724
申请日:2003-07-16
Applicant: BAXTER HEALTHCARE SA , BAXTER INT
Inventor: CHILDERS ROBERT W , BROWN DAVID S , WARIAR RAMESH , KAROOR SUJATHA , DIN SHAHID , MARTIS LEO , BUCHMANN CODY , SOLTYS PAUL
-
公开(公告)号:AT505223T
公开(公告)日:2011-04-15
申请号:AT03765630
申请日:2003-07-16
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: CHILDERS ROBERT W , BROWN DAVID S , WARIAR RAMESH , KAROOR SUJATHA , DIN SHAHID , MARTIS LEO , BUCHMANN CODY , SOLTYS PAUL
Abstract: A system for dialysis is disclosed. An example peritoneal dialysis system includes a peritoneal dialysis machine including a pumping mechanism, and a sensor configured to measure a property of peritoneal dialysis fluid. The peritoneal dialysis system also includes a disposable cassette operable with the peritoneal dialysis machine. The disposable cassette includes a fluid source inlet for accepting fluid from a fluid source and a fluid flow path in fluid communication with the fluid source inlet. The fluid flow path includes a pump chamber operable with the pumping mechanism to pump fluid through the fluid flow path. The disposable cassette also includes a concentrate inlet for fluidly communicating concentrate to the fluid flow path, and a sensor chamber located along the fluid flow path and operable with the sensor. The sensor is configured to provide feedback to the peritoneal dialysis machine for mixing the concentrate for forming peritoneal dialysis fluid.
-
6.
公开(公告)号:ES2321631T3
公开(公告)日:2009-06-09
申请号:ES05713781
申请日:2005-02-18
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MARTIS LEO , PATEL MEHUL , GIERTYCH JOSEPH A , MONGOVEN JAMES W , KUNZLER JACQUELINE A , OWEN WILLIAM F JR
IPC: C12Q1/37 , C12Q1/04 , C12Q1/26 , G01N33/569
Abstract: Método para fabricar una solución de diálisis peritoneal, comprendiendo el método las fases de: proporcionar un polímero de glucosa; realizar un análisis de biocarga para organismos termófilos acidófilos con el fin de detectar la presencia de Alicyclobacillus acidocaldorius; esterilizar el polímero de glucosa; añadir un reactivo al polímero de glucosa, pudiendo el reactivo reaccionar con un peptidoglicano; determinar la cantidad de peptidoglicano; y utilizar el polímero de glucosa para preparar la solución de diálisis peritoneal si se determina que está presente un nivel suficientemente bajo de peptidoglicano.
-
公开(公告)号:ES2272304T3
公开(公告)日:2007-05-01
申请号:ES00950792
申请日:2000-07-27
Applicant: BAXTER INT
Inventor: DUPONCHELLE ANNICK , FAICT DIRK , BALTEAU PATRICK , HARTMAN JEAN-PIERRE , MARTIS LEO , PELUSO FRANCESCO
IPC: A61J3/00 , A61K33/10 , A61J1/05 , A61J1/10 , A61J1/20 , A61K33/14 , A61M1/14 , A61M1/16 , A61M1/28 , A61P13/12
Abstract: Solución en dos partes que contiene bicarbonato comprendiendo dicha solución: una primera parte alojada en un primer recipiente, incluyendo la primera parte un concentrado de bicarbonato alcalino cuyo pH oscila entre 8, 6 y 10, 0; una segunda parte alojada en un segundo recipiente, incluyendo la segunda parte un concentrado ácido cuyo pH oscila entre 1, 0 y menos de 3, 0, siendo el pH del concentrado ácido efectivo para obtener, cuando se mezclan conjuntamente la primera y segunda partes, una solución mezcla cuyo pH oscila entre 6, 5 y 7, 6.
-
公开(公告)号:BR0317450A
公开(公告)日:2005-11-16
申请号:BR0317450
申请日:2003-12-18
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MARTIS LEO , CHOO CAROLYN , ZIESKE PAUL
IPC: A61K31/718 , A61K31/724 , A61M1/28
Abstract: Icodextrin-based solutions and methods of making same that can be used during medical therapy, such as dialysis therapy are provided. The icodextrin-based solution at least includes a first solution containing icodextrin at a pH ranging from about 1.5 to about 5.0 and a buffer solution at a pH ranging from about 7.0 to about 12.0 that are so constructed and arranged allowing the icodextrin-based solution to be mixed prior to infusion into a patient. The icodextrin-based solutions of the present invention can be made at physiologic pH and with minimal glucose degradation products.
-
公开(公告)号:DE69531426D1
公开(公告)日:2003-09-11
申请号:DE69531426
申请日:1995-01-23
Applicant: BAXTER INT
Inventor: MARTIS LEO , BURKE RON , SHOCKLEY TY , HENDERSON LEE W , FALLER BERNARDETTE
IPC: A61K31/715 , A61K33/14 , A61M1/28 , A61M1/14
Abstract: The method relates to providing an osmotic agent for a peritoneal dialysis solution containing sodium chloride and optionally lactate, bicarbonate, calcium and magnesium ions. The osmotic agent added comprises a first composition with a weight average molecular weight of ≥ 10,000 daltons and 0.25 to 2.0 (% w/v) of a second composition with a weight average molecular weight of ≤ 300 daltons.
-
公开(公告)号:DE69332106T2
公开(公告)日:2003-02-27
申请号:DE69332106
申请日:1993-12-10
Applicant: BAXTER INT
Inventor: MARTIS LEO , FAICT DIRK , BURKE RON
IPC: A61K9/08 , A61K31/70 , A61K33/00 , A61K38/00 , A61K38/01 , A61K38/02 , A61K47/26 , A61K47/42 , A61M1/14 , A61M1/28 , A61P7/08 , A61M1/18
Abstract: The solution contains as osmotic agents both dectrose and polypeptides. The polypeptides are synthetic and are 4 to 10 amino acids long.
-
-
-
-
-
-
-
-
-